London Borough of Bromley, England – November 18, 2025 – PRESSADVANTAGE – Smile 4 U – Bromley has announced the availability ...

Immunome (IMNM) surges after positive phase 3 results for varegacestat in desmoid tumors. Read the latest analysis on the ...

The FDA has cleared the initiation of a pivotal Phase 3 trial testing pridopidine in people with early, rapidly progressive ...

Neurocrine Biosciences ($NBIX) announced an update on their ongoing clinical study. Neurocrine Biosciences has announced the initiation of a Phase ...

Combining elacestrant with targeted agents produced “clinically meaningful” outcomes for patients with locally advanced or metastatic ER-positive/HER2-negative breast cancer who have received at least ...

San Diego–based Ventyx Biosciences has what pharma wants, according to William Blair: two NLRP3 inhibitors for inflammatory ...

Patients with gout receiving oral ULT showed similar rates of MSU crystal dissolution in the joints and tendons.

There is increasing evidence that gum disease is associated with an increased risk of cardiovascular events, including heart ...

London Borough of Croydon, England – December 15, 2025 – PRESSADVANTAGE – Smile 4 U – Croydon has announced expanded ...

Zoliflodacin is an oral spiropyrimidinetrione antibiotic with activity against multidrug-resistant strains of Neisseria gonorrhoeae.

In pediatric-onset multiple sclerosis, switching to oral or infusion therapies was linked to fewer relapses than switching between injectable treatments.

The U.S. Food and Drug Administration recently approved two new oral medicines to treat the sexually transmitted infection ...